Analysis date: 2026-05-31 | Country: SE | Currency: SEK
| Field | Value |
|---|---|
| Rating | Buy |
| Intrinsic Value | 155.0 SEK |
| 24m Target | 140.0 SEK |
| Price at Analysis | 124.4 SEK |
| Buffett Score | 15/20 |
| ROIC | 61.9% |
| Economic Profit | +286.1M SEK |
| Implied Upside (IV) | 24.6% |
Ticker: BIOG-B.ST | Name: BioGaia B | Country: SE | Sector: Industrial/Commercial
BioGaia B operates in the Nordic market. ROIC 61.9% vs WACC 8% → EP +286.1M SEK.
Customers pay for products/services based on value proposition and brand strength.
Revenue generated through product/service sales. Scalability and recurring revenue characteristics vary by segment.
ROIC 61.9% vs WACC 8.0% → Economic Profit +286.1M SEK.
Raw materials, suppliers, distribution channels, and human capital.
Moat strength: 5/5. Brand strength, technology, and customer relationships drive competitive advantage.
Market penetration, geographic expansion, and product development.
Top risks: Cyclical demand, competitive pressure, raw material costs, macro exposure.
Established Nordic industrial company with stable management.
Buy — BioGaia B: Strong value creation, ROIC 61.9% >> WACC 8%, attractive at current price.
mttssn research · BioGaia B (BIOG-B.ST) · 2026-W158 · 2026-05-31